A carregar...
EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib
BACKGROUND: EGFR exon 20 insertions (exon20ins) represent approximately 10% of EGFR-mutant lung adenocarcinomas and are associated with resistance to EGFR tyrosine kinase inhibitors (TKIs). Clinical outcomes compared to patients with sensitizing EGFR mutations are not well-established. METHODS: Pati...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807634/ https://ncbi.nlm.nih.gov/pubmed/26096453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29493 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|